ScinoPharm Taiwan

ScinoPharm Taiwan is a company listed under the stock ticker 1789 (TW).

View the org chart displaying its 20 main executives

Most searched biographies at ScinoPharm Taiwan

• Li-An Lu, President and Chief Executive Officer
• Jang-Yang Chang, Independent Director
• Wenchang Zhang, Independent Director

Create your alert
to follow the executive moves at ScinoPharm Taiwan.

ScinoPharm Taiwan has 1,859 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Danilo Cicmil - Supervisory Board Member at Galenika
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by ScinoPharm Taiwan

Social media about ScinoPharm Taiwan

• ScinoPharm Taiwan on Wikipedia, Google News & Yahoo Finance
• ScinoPharm Taiwan on LinkedIn, Twitter & YouTube

Contact by email its executives including Li-An Lu

Call ScinoPharm Taiwan at +886 ...

View the org chart

Register to receive your alert

Report an error